Background: En bloc wide-margin excision significantly decreases the risk of chordoma recurrence. However, a wide surgical margin cannot be obtained in many chordomas because they arise primarily in the sacrum, clivus, and mobile spine. Furthermore, these tumors have shown resistance to fractionated photon radiation at conventional doses and numerous chemotherapies.
Objective: To analyze the outcomes of single-fraction stereotactic radiosurgery (SRS) in the treatment of chordomas of the mobile spine and sacrum.
Methods: Twenty-four patients with chordoma of the sacrum and mobile spine were treated with high-dose single-fraction SRS (median dose, 2400 cGy). Twenty-one primary and 3 metastatic tumors were treated. Seven patients were treated for postoperative tumor recurrence. In 7 patients, SRS was administered as planned adjuvant therapy, and in 13 patients, SRS was administered as neoadjuvant therapy. All patients had serial magnetic resonance imaging follow-up.
Results: The overall median follow-up was 24 months. Of the 24 patients, 23 (95%) demonstrated stable or reduced tumor burden based on serial magnetic resonance imaging. One patient had radiographic progression of tumor 11 months after SRS. Only 6 of 13 patients who underwent neoadjuvant SRS proceeded to surgery. This decision was based on the lack of radiographic progression and the patient's preference. Complications were limited to 1 patient in whom sciatic neuropathy developed and 1 with vocal cord paralysis.
Conclusion: High-dose single-fraction SRS provides good tumor control with low treatment-related morbidity. Additional follow-up is required to determine the long-term recurrence risk.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1227/NEU.0000000000000083 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Good response of stage IV melanoma to high‑dose radiation therapy combined with immunotherapy: A case report.
Oncol Lett
December 2024
Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Article Synopsis
- - The study focuses on a 51-year-old woman with stage IV malignant melanoma who underwent a combination of immune checkpoint inhibitors and various forms of radiotherapy, achieving nearly complete remission in specific areas.
- - After treatment, she experienced significant pain relief and an improved quality of life for several months, with localized lung lesions also showing controlled response to lower doses of radiation.
- - Despite initial success, the patient later developed new brain and abdominal metastases, suggesting that while this combined approach may offer hope for advanced melanoma treatment, outcomes can vary and new challenges may arise.
Combined external radiotherapy and single-fraction palliative high-dose-rate interstitial brachytherapy for a patient with a base of tongue cancer who had a previous radiation history.
Oral Radiol
October 2024
Department of Radiology, Kansai Medical University Hospital, Osaka, Japan.
Article Synopsis
- A study explored the use of high-dose-rate interstitial brachytherapy (HDR-ISBT) as palliative treatment for an 81-year-old male with base of tongue cancer, following prior radiation and treatment.
- The patient underwent a lower-dose external beam radiotherapy (ERT) followed by a single-fraction HDR-ISBT booster, with precautions taken to minimize infection and bleeding.
- Post-treatment results showed significant tumor reduction, pain relief, and no complications after nearly three years, indicating HDR-ISBT could be an effective palliative care option for patients in similar situations.
Redefining FLASH Radiation Therapy: The Impact of Mean Dose Rate and Dose Per Pulse in the Gastrointestinal Tract.
Int J Radiat Oncol Biol Phys
October 2024
Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas. Electronic address:
Purpose: The understanding of how varying radiation beam parameter settings affect the induction and magnitude of the FLASH effect remains limited. We sought to systematically evaluate how the magnitude of radiation-induced gastrointestinal toxicity depends on the interplay between mean dose rate (MDR) and dose per pulse (DPP).
Methods And Materials: C57BL/6J mice received total abdominal irradiation (TAI, 11-14 Gy single fraction) through either conventional (CONV) irradiation (low-DPP and low MDR, CONV) or through various combinations of DPP and MDR up to ultra-high-dose-rate beam conditions.
Hybrid ultra-high and conventional dose rate treatments with electrons and photons for the clinical transfer of FLASH-RT to deep-seated targets: A treatment planning study.
Radiother Oncol
December 2024
Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. Electronic address:
Purpose: This study explores the dosimetric feasibility and plan quality of hybrid ultra-high dose rate (UHDR) electron and conventional dose rate (CDR) photon (HUC) radiotherapy for treating deep-seated tumours with FLASH-RT.
Methods: HUC treatment planning was conducted optimizing a broad UHDR electron beam (between 20-250 MeV) combined with a CDR VMAT for a glioblastoma, a pancreatic cancer, and a prostate cancer case. HUC plans were based on clinical prescription and fractionation schemes and compared against clinically delivered plans.
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.
Sci Transl Med
September 2024
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
Radiation therapy (RT) activates multiple immunologic effects in the tumor microenvironment (TME), with diverse dose-response relationships observed. We hypothesized that, in contrast with homogeneous RT, a heterogeneous RT dose would simultaneously optimize activation of multiple immunogenic effects in a single TME, resulting in a more effective antitumor immune response. Using high-dose-rate brachytherapy, we treated mice bearing syngeneic tumors with a single fraction of heterogeneous RT at a dose ranging from 2 to 30 gray.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!